Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 217Precursor Cell Lymphoblastic Leukemia-Lymphoma 192Lymphoma, Large B-Cell, Diffuse 173Burkitt Lymphoma 91Lymphoma, Non-Hodgkin 90Leukemia 80Lymphoma, Follicular 79Lymphoma, Mantle-Cell 53Hodgkin Disease 46Lymphoma, B-Cell 31Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 30Lymphoma, Large-Cell, Anaplastic 29Lymphoma, T-Cell, Peripheral 28Lymphoma, Large-Cell, Immunoblastic 27Recurrence 24Lymphoma, B-Cell, Marginal Zone 22Leukemia, Lymphocytic, Chronic, B-Cell 21Lymphoma, T-Cell 17Leukemia, Biphenotypic, Acute 17Dendritic Cell Sarcoma, Interdigitating 17Immunoblastic Lymphadenopathy 16Neoplasms 14Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 11HIV Infections 10Waldenstrom Macroglobulinemia 7Enteropathy-Associated T-Cell Lymphoma 7Blast Crisis 7Multiple Myeloma 6Lymphoma, T-Cell, Cutaneous 6Lymphoma, AIDS-Related 6

Interventions

Vincristine 1Rituximab 1Prednisone 1Etoposide 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
HIV Seropositivity × Vincristine × Lymphoid × Clear all
NCT01092182 2023-04-27

Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
194 enrolled 19 charts
Lymphoid

Plasmablastic Lymphoma, Burkitt Lymphoma, HIV Seropositivity, HIV Infections, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡